The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.
Mediouni S, Kessing CF, Jablonski JA, Thenin-Houssier S, Clementz M, Kovach MD, Mousseau G, de Vera IMS, Li C, Kojetin DJ, Evans DT, Valente ST.
Mediouni S, et al. Among authors: jablonski ja.
FASEB J. 2019 Jul;33(7):8280-8293. doi: 10.1096/fj.201801165R. Epub 2019 Apr 25.
FASEB J. 2019.
PMID: 31021670
Free PMC article.
In sum, dCA's remarkable breadth of activity encourages SIV-infected RhM use for dCA preclinical evaluation.-Mediouni, S., Kessing, C. F., Jablonski, J. A., Thenin-Houssier, S., Clementz, M., Kovach, M. D., Mousseau, G., de Vera, I.M.S., Li, C., Kojetin, D. J …
In sum, dCA's remarkable breadth of activity encourages SIV-infected RhM use for dCA preclinical evaluation.-Mediouni, S., Kessing, C. F., …